Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EV/Net Sales

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

TORRENT PHARMACEUTICALS Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 9.728.505.905.995.90

What is the latest EV/Net Sales ratio of TORRENT PHARMACEUTICALS ?

The latest EV/Net Sales ratio of TORRENT PHARMACEUTICALS is 9.72 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20259.72
Mar20248.50
Mar20235.90
Mar20225.99
Mar20215.90

How is EV/Net Sales of TORRENT PHARMACEUTICALS Trending?

Years EV/Net Sales % Change
Mar2025 9.72
14.35
Mar2024 8.5
44.07
Mar2023 5.9
-1.50
Mar2022 5.99
1.53
Mar2021 5.9 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EV/Net Sales ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹136,327.8 Cr 1.7% 4.1% 20.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,847.0 Cr 6.8% -1.5% -2.4% Stock Analytics
DIVIS LABORATORIES ₹160,745.0 Cr 0% -4.8% 8.3% Stock Analytics
CIPLA ₹107,075.0 Cr 0.1% -12.8% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,507.0 Cr 1.8% -0.7% 3.4% Stock Analytics
MANKIND PHARMA ₹86,263.9 Cr -1.7% -4.7% -13.4% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

1.7%

4.1%

20.5%

SENSEX

1.5%

-2.3%

9.5%


You may also like the below Video Courses